Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future
M Rey-Cárdenas, F Guerrero-Ramos… - Cancer treatment …, 2021 - Elsevier
Urothelial bladder cancer (UC) is the most common malignancy involving the urinary system
and represents a significant health problem. Immunotherapy has been used for decades for …
and represents a significant health problem. Immunotherapy has been used for decades for …
[HTML][HTML] Neoadjuvant immunotherapy in gastrointestinal cancers–The new standard of care?
B Petricevic, J Kabiljo, R Zirnbauer, H Walczak… - Seminars in cancer …, 2022 - Elsevier
The development of immune checkpoint inhibitors (ICI) offers novel treatment possibilities for
solid cancers, with the crucial benefit of providing higher cure rates. These agents have …
solid cancers, with the crucial benefit of providing higher cure rates. These agents have …
[HTML][HTML] Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆
Background Initial studies of preoperative checkpoint inhibition before radical cystectomy
(RC) have shown promising pathologic complete responses. We aimed to analyze the …
(RC) have shown promising pathologic complete responses. We aimed to analyze the …
[18F] Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving …
Background Data regarding the role of positron emission tomography/computed tomography
(PET/CT) to stage lymph nodes in patients receiving neoadjuvant immunotherapy before …
(PET/CT) to stage lymph nodes in patients receiving neoadjuvant immunotherapy before …
Blasenkarzinomsystemtherapie
M Haas, M Burger, MJ Schnabel - Der Urologe, 2021 - Springer
Zusammenfassung Die Cisplatin-basierte Polychemotherapie stellt in der Systemtherapie
des muskelinvasiven Harnblasenkarzinoms („muscle-invasive bladder cancer “, MIBC) seit …
des muskelinvasiven Harnblasenkarzinoms („muscle-invasive bladder cancer “, MIBC) seit …
Is it time to consider eliminating surgery from the treatment of locally advanced bladder cancer?
A Necchi, L Marandino, D Raggi, M Bandini… - European …, 2020 - europepmc.org
The similar clinical behavior, overlapping therapeutic patterns, and several clinical trials
addressing the neoadjuvant and first-line therapy settings for bladder cancer support the call …
addressing the neoadjuvant and first-line therapy settings for bladder cancer support the call …